Results from open-label Raptiva study suggest continued benefit with long-term treatment
...scovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs. Fifteen of the currently approved biotechnology products originated from or are based on Genentech science. Genentech manufactures and commercializes ten biotechnology products directly in the United States. Th...Phase III study results with Raptiva in the treatment of psoriasis presented at Annual AAD meeting
...scovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs. Fifteen of the currently approved biotechnology products originated from or are based on Genentech science. Genentech manufactures and commercializes ten biotechnology products directly in the United States. Th...FDA approves Raptiva (efalizumab) for chronic moderate-to-severe plaque psoriasis
...scovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs. Sixteen of the currently approved biotechnology products originated from or are based on Genentech science. Genentech manufactures and commercializes 12 biotechnology products in the United States. The company has...University of Pittsburgh Medical Center acquires biotechnology firm Rheogene Inc.
...gulation systems for drug discovery, gene therapy, biotherapeutics production, agriculture and biosensors. RheoGene's RheoPlex technology consists of multiple molecular switches that independently regulate spatial and temporal expression of more than one gene at a time in the same cell, or in different cell types in...